首页> 外文期刊>Psycho-Oncology: Journal of the Psychological Social and Behavioral Dimensions of Cancer >Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.
【24h】

Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.

机译:乳腺癌患者的治疗前症状群与化疗期间较差的睡眠,疲劳和沮丧感相关。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The concept of symptom clusters is relatively new in cancer patients' symptom management. This study, which spanned four cycles of chemotherapy, combined three commonly seen pre-treatment symptoms in cancer patients (i.e. sleep disturbances, fatigue and depression) into one symptom cluster, to explore the associations between pre-treatment cluster categories and longitudinal profiles of these same symptoms during chemotherapy. METHODS: This was a prospective study. Seventy-six women with newly diagnosed stage I-III breast cancer, scheduled to receive at least four cycles of adjuvant or neoadjuvant anthracycline-based chemotherapy participated. Data were collected at seven time points before and during treatment. Sleep quality was measured with the Pittsburgh Sleep Quality Index. Fatigue was measured with the Multidimensional Fatigue Symptom Inventory--Short Form. Depressive symptoms were measured with the Center of Epidemiological Studies--Depression. Patients were divided into three groups based on the number of symptoms they experienced before the start of chemotherapy (i.e. no symptoms, 1-2 symptoms or all three symptoms) and a symptom cluster index (SCI) was computed. RESULTS: All women reported worse sleep, more fatigue and more depressive symptoms during treatment compared with baseline (all p's<0.01); however, those women with a higher SCI (i.e. more symptoms pre-treatment) continued to experience worse symptoms during treatment compared with those who began with fewer symptoms (all p's<0.01). CONCLUSIONS: A higher clinically relevant-based pre-treatment symptom cluster was associated with more sleep disturbances, greater fatigue and more depressive symptoms during chemotherapy. Specific interventions for these pre-treatment symptoms may improve the frequency and severity of these same symptoms during chemotherapy, when they are most severe and most disruptive to quality of life.
机译:目的:症状簇的概念在癌症患者的症状管理中相对较新。这项研究涵盖了四个化疗周期,将癌症患者中三种常见的治疗前症状(即睡眠障碍,疲劳和抑郁)合并为一个症状组,以探讨治疗前组类别与这些症状的纵向特征之间的关联。化疗期间的症状相同。方法:这是一项前瞻性研究。计划接受至少四个周期以蒽环类为基础的辅助或新辅助化疗的76名新诊断为I-III期乳腺癌的妇女参加了研究。在治疗前和治疗中的七个时间点收集数据。睡眠质量用匹兹堡睡眠质量指数来衡量。使用多维疲劳症状清单-简短表格测量疲劳。抑郁症状是通过流行病学研究中心-抑郁症进行测量的。根据患者在开始化疗之前经历的症状数(即无症状,1-2个症状或所有三个症状)将患者分为三组,并计算症状簇指数(SCI)。结果:与基线相比,所有妇女在治疗期间均报告睡眠较差,疲劳和抑郁症状更严重(所有p均<0.01);但是,与开始时症状较少的女性相比,那些具有较高SCI(即治疗前症状较多)的女性继续在治疗期间出现较差的症状(所有p均<0.01)。结论:较高的基于临床相关性的治疗前症状簇与化疗期间更多的睡眠障碍,更多的疲劳和更多的抑郁症状相关。当这些症状最严重且对生活质量造成最大破坏时,针对这些预处理症状的特定干预措施可能会改善这些相同症状在化疗期间的发生频率和严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号